Dr Krishnan on the Complexity of Developing a Consensus for Risk Stratification in Smoldering Myeloma

Amrita Krishnan, MD, professor, Department of Hematology & Hematopoietic Cell Transplantation, director, the Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, executive medical director, Hematology, City of Hope Orange County, highlights the complexity of risk stratification in smoldering multiple myeloma.

Challenges exist due to the existence of multiple classification models. Despite the lack of a single standardized model, there is broad agreement on key prognostic factors that define high-risk smoldering myeloma. These considerations were discussed at the Bridging The Gaps: Leukemia, Lymphoma, and Multiple Myeloma meeting in Miami, Florida.